1. Home
  2. SPRC vs CERO Comparison

SPRC vs CERO Comparison

Compare SPRC & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • CERO
  • Stock Information
  • Founded
  • SPRC 2004
  • CERO 2017
  • Country
  • SPRC Israel
  • CERO United States
  • Employees
  • SPRC N/A
  • CERO N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • CERO
  • Sector
  • SPRC Health Care
  • CERO
  • Exchange
  • SPRC Nasdaq
  • CERO Nasdaq
  • Market Cap
  • SPRC 3.1M
  • CERO 3.1M
  • IPO Year
  • SPRC N/A
  • CERO N/A
  • Fundamental
  • Price
  • SPRC $0.32
  • CERO $0.59
  • Analyst Decision
  • SPRC
  • CERO Strong Buy
  • Analyst Count
  • SPRC 0
  • CERO 1
  • Target Price
  • SPRC N/A
  • CERO $11.00
  • AVG Volume (30 Days)
  • SPRC 5.9M
  • CERO 4.2M
  • Earning Date
  • SPRC 02-15-2025
  • CERO 05-27-2025
  • Dividend Yield
  • SPRC N/A
  • CERO N/A
  • EPS Growth
  • SPRC N/A
  • CERO N/A
  • EPS
  • SPRC N/A
  • CERO N/A
  • Revenue
  • SPRC $1,306,000.00
  • CERO N/A
  • Revenue This Year
  • SPRC N/A
  • CERO N/A
  • Revenue Next Year
  • SPRC N/A
  • CERO N/A
  • P/E Ratio
  • SPRC N/A
  • CERO N/A
  • Revenue Growth
  • SPRC N/A
  • CERO N/A
  • 52 Week Low
  • SPRC $0.20
  • CERO $0.53
  • 52 Week High
  • SPRC $1.79
  • CERO $147.00
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 50.23
  • CERO 36.01
  • Support Level
  • SPRC $0.30
  • CERO $0.55
  • Resistance Level
  • SPRC $0.38
  • CERO $0.62
  • Average True Range (ATR)
  • SPRC 0.04
  • CERO 0.06
  • MACD
  • SPRC 0.00
  • CERO -0.01
  • Stochastic Oscillator
  • SPRC 25.77
  • CERO 7.74

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

Share on Social Networks: